Skip Nav Destination
Issues
15 October 2014
-
Cover Image
Cover Image
The cover shows the expression of long noncoding RNAs in normal and malignant bladder urothelium as detected by microarray. Unsupervised hierarchical clustering reveals discrimination of normal, low-grade and high-grade malignant tissues. For details, see the article by Peter and colleagues on page 5311 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
CCR New Strategies
Molecular Pathways
CCR Focus
New Paradigms in Mantle Cell Lymphoma: Is It Time to Risk-Stratify Treatment Based on the Proliferative Signature?
Martin Dreyling; Simone Ferrero; Niklas Vogt; Wolfram Klapper; on behalf of the European Mantle Cell Lymphoma Network
Cancer Therapy: Clinical
A Phase I Study of the First-in-Class Antimitochondrial Metabolism Agent, CPI-613, in Patients with Advanced Hematologic Malignancies
Timothy S. Pardee; King Lee; John Luddy; Claudia Maturo; Robert Rodriguez; Scott Isom; Lance D. Miller; Kristin M. Stadelman; Denise Levitan; David Hurd; Leslie R. Ellis; Robin Harrelson; Megan Manuel; Sarah Dralle; Susan Lyerly; Bayard L. Powell
Personalized Medicine and Imaging
Development and Validation of a Gene Profile Predicting Benefit of Postmastectomy Radiotherapy in Patients with High-Risk Breast Cancer: A Study of Gene Expression in the DBCG82bc Cohort
Trine Tramm; Hayat Mohammed; Simen Myhre; Marianne Kyndi; Jan Alsner; Anne-Lise Børresen-Dale; Therese Sørlie; Arnoldo Frigessi; Jens Overgaard
Author Choice
Pharmacogenomic Modeling of Circulating Tumor and Invasive Cells for Prediction of Chemotherapy Response and Resistance in Pancreatic Cancer
Kenneth H. Yu; Mark Ricigliano; Manuel Hidalgo; Ghassan K. Abou-Alfa; Maeve A. Lowery; Leonard B. Saltz; Joseph F. Crotty; Kristen Gary; Brandon Cooper; Rena Lapidus; Mariola Sadowska; Eileen M. O'Reilly
Cancer Therapy: Preclinical
Biology of Human Tumors
Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies
Sabine Venderbosch; Iris D. Nagtegaal; Tim S. Maughan; Christopher G. Smith; Jeremy P. Cheadle; David Fisher; Richard Kaplan; Philip Quirke; Matthew T. Seymour; Susan D. Richman; Gerrit A. Meijer; Bauke Ylstra; Danielle A.M. Heideman; Anton F.J. de Haan; Cornelis J.A. Punt; Miriam Koopman
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds